Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Toth

Showing results (331-340 of 524) with videos related to

Pageof 53
Sort By:
Journal of Clinical Lipidology|March 6, 2012
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reductionPeter P Toth, Christie M Ballantyne, Michael H Davidson, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|June 13, 2009
HIV/STD prevalence, risk behavior, and substance use patterns and predictors in Russian and Hungarian sociocentric social networks of men who have sex with menYuri A Amirkhanian, Jeffrey A Kelly, Judit Takacs, et al.
The American Journal of Cardiology|March 12, 2015
Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapyChristopher J Franzese, Kevin P Bliden, Martin G Gesheff, et al.
Journal of Interventional Cardiology|January 30, 2016
Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent RestenosisKevin P Bliden, Udaya S Tantry, Martin G Gesheff, et al.
Frontiers in Pharmacology|January 19, 2016
Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective StudyPeter P Toth, Angelo M Patti, Dragana Nikolic, et al.
Environmental Pollution (Barking, Essex : 1987)|January 18, 2006
Effects of eutrophication on vitellogenin gene expression in male fathead minnows (Pimephales promelas) exposed to 17alpha-ethynylestradiol in field mesocosmsDenise A Gordon, Gregory P Toth, David W Graham, et al.
The American Journal of Cardiology|December 10, 2017
Effect of Evolocumab on Lipoprotein ParticlesPeter P Toth, Naveed Sattar, Dirk J Blom, et al.
Journal of the American Heart Association|April 24, 2014
Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B)Kristopher J Swiger, Seth S Martin, Michael J Blaha, et al.
Current Medical Research and Opinion|August 9, 2017
Low-density lipoprotein 4: a novel predictor of coronary artery disease severityRahul Chaudhary, Denny Mathew, Kevin Bliden, et al.
Vascular Health and Risk Management|February 15, 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular diseaseThomas P Power, Xuehua Ke, Zhenxiang Zhao, et al.
Pageof 53

Showing results (331-340 of 524) with videos related to

Sort By:
Pageof 53
Journal of Clinical Lipidology|March 6, 2012
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reductionPeter P Toth, Christie M Ballantyne, Michael H Davidson, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|June 13, 2009
HIV/STD prevalence, risk behavior, and substance use patterns and predictors in Russian and Hungarian sociocentric social networks of men who have sex with menYuri A Amirkhanian, Jeffrey A Kelly, Judit Takacs, et al.
The American Journal of Cardiology|March 12, 2015
Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapyChristopher J Franzese, Kevin P Bliden, Martin G Gesheff, et al.
Journal of Interventional Cardiology|January 30, 2016
Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent RestenosisKevin P Bliden, Udaya S Tantry, Martin G Gesheff, et al.
Frontiers in Pharmacology|January 19, 2016
Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective StudyPeter P Toth, Angelo M Patti, Dragana Nikolic, et al.
Environmental Pollution (Barking, Essex : 1987)|January 18, 2006
Effects of eutrophication on vitellogenin gene expression in male fathead minnows (Pimephales promelas) exposed to 17alpha-ethynylestradiol in field mesocosmsDenise A Gordon, Gregory P Toth, David W Graham, et al.
The American Journal of Cardiology|December 10, 2017
Effect of Evolocumab on Lipoprotein ParticlesPeter P Toth, Naveed Sattar, Dirk J Blom, et al.
Journal of the American Heart Association|April 24, 2014
Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B)Kristopher J Swiger, Seth S Martin, Michael J Blaha, et al.
Current Medical Research and Opinion|August 9, 2017
Low-density lipoprotein 4: a novel predictor of coronary artery disease severityRahul Chaudhary, Denny Mathew, Kevin Bliden, et al.
Vascular Health and Risk Management|February 15, 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular diseaseThomas P Power, Xuehua Ke, Zhenxiang Zhao, et al.
Pageof 53